<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To evaluate the safety and efficacy of the Ahmed <z:hpo ids='HP_0000501'>glaucoma</z:hpo> valve implant in patients with <z:hpo ids='HP_0000501'>glaucoma</z:hpo> as a result of <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Eleven eyes (10 patients) with <z:hpo ids='HP_0000501'>glaucoma</z:hpo> resulting from <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> had placement of an Ahmed <z:hpo ids='HP_0000501'>glaucoma</z:hpo> valve implant from May 1993 to June 1996 at the Jules Stein Eye Institute </plain></SENT>
<SENT sid="2" pm="."><plain>Success was defined by intraocular pressure at the last two consecutive visits of less than 21 mm Hg, no additional <z:hpo ids='HP_0000501'>glaucoma</z:hpo> surgery, no expulsive <z:hpo ids='HP_0011887'>choroidal hemorrhage</z:hpo>, and no <z:hpo ids='HP_0000541'>retinal detachment</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Mean intraocular pressure on the first postoperative day was 14.0 mm Hg (SD +/- 6.7) </plain></SENT>
<SENT sid="4" pm="."><plain>The cumulative probability of success was 79% (95% confidence interval [CI], 52% to 100%) at 24 months, 59% (95% CI, 20% to 98%) at 42 months, and 30% (95% CI, 0% to 75%) at 60 months </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: On the basis of limited follow-up, the Ahmed <z:hpo ids='HP_0000501'>glaucoma</z:hpo> valve implant appears to be a relatively useful drainage device in eyes with <z:hpo ids='HP_0000501'>glaucoma</z:hpo> resulting from <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> </plain></SENT>
</text></document>